These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3619161)

  • 1. Intravenous theophylline poisoning and multiple-dose charcoal in an animal model.
    Kulig KW; Bar-Or D; Rumack BH
    Ann Emerg Med; 1987 Aug; 16(8):842-6. PubMed ID: 3619161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-bowel irrigation as adjunctive treatment for sustained-release theophylline overdose.
    Burkhart KK; Wuerz RC; Donovan JW
    Ann Emerg Med; 1992 Nov; 21(11):1316-20. PubMed ID: 1416325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of theophylline clearance in gastrointestinal dialysis with charcoal.
    Huang JD
    J Pharm Sci; 1987 Jul; 76(7):525-7. PubMed ID: 3668813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication.
    Ohning BL; Reed MD; Blumer JL
    Pediatr Pharmacol (New York); 1986; 5(4):241-5. PubMed ID: 3737269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics.
    Mckinnon RS; Desmond PV; Harman PJ; Kamm M; Ghabrial H; Martin CJ; Mashford ML
    J Pharm Pharmacol; 1987 Jul; 39(7):522-5. PubMed ID: 2886620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated charcoal in theophylline intoxication.
    Brashear RE; Aronoff GR; Brier RA
    J Lab Clin Med; 1985 Sep; 106(3):242-5. PubMed ID: 4031629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum theophylline clearance with orally administered activated charcoal.
    Mahutte CK; True RJ; Michiels TM; Berman JM; Light RW
    Am Rev Respir Dis; 1983 Nov; 128(5):820-2. PubMed ID: 6638669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of size and frequency of oral doses of charcoal on theophylline clearance.
    Park GD; Radomski L; Goldberg MJ; Spector R; Johnson GF; Quee CK
    Clin Pharmacol Ther; 1983 Nov; 34(5):663-6. PubMed ID: 6627827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the surface area of activated charcoal on theophylline clearance.
    Park GD; Spector R; Goldberg MJ; Johnson GF; Feldman R; Quee CK
    J Clin Pharmacol; 1984 Jul; 24(7):289-92. PubMed ID: 6480875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1988 Feb; 40(2):101-5. PubMed ID: 2897439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of theophylline clearance by oral activated charcoal.
    Berlinger WG; Spector R; Goldberg MJ; Johnson GF; Quee CK; Berg MJ
    Clin Pharmacol Ther; 1983 Mar; 33(3):351-4. PubMed ID: 6337763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination.
    Rygnestad T; Walstad RA; Dahl K
    Acta Med Scand; 1986; 219(4):425-7. PubMed ID: 3716886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated charcoal surface area and its role in multiple-dose charcoal therapy.
    Ilkhanipour K; Yealy DM; Krenzelok EP
    Am J Emerg Med; 1993 Nov; 11(6):583-5. PubMed ID: 8240556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of theophylline toxicity with oral activated charcoal.
    Sessler CN; Glauser FL; Cooper KR
    Chest; 1985 Mar; 87(3):325-9. PubMed ID: 3971756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy.
    Chyka PA; Holley JE; Mandrell TD; Sugathan P
    Ann Emerg Med; 1995 Mar; 25(3):356-62. PubMed ID: 7864477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple dose activated charcoal for theophylline poisoning in young infants.
    Shannon M; Amitai Y; Lovejoy FH
    Pediatrics; 1987 Sep; 80(3):368-70. PubMed ID: 3627887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal.
    Lim DT; Singh P; Nourtsis S; Dela Cruz R
    Ann Emerg Med; 1986 Nov; 15(11):1303-7. PubMed ID: 3777587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.
    J Toxicol Clin Toxicol; 1999; 37(6):731-51. PubMed ID: 10584586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of theophylline toxicity with oral activated charcoal.
    True RJ; Berman JM; Mahutte CK
    Crit Care Med; 1984 Feb; 12(2):113-4. PubMed ID: 6697727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.